Search
Showing 1 - 5 of 5 results
UCSF-led Clinical Trial of Patients with Juvenile Arthritis-associated Uveitis Validates Continued Treatment with Adalimumab
In a study published last January in The Lancet, UCSF researchers sought to assess efficacy and safety of discontinuing treatment in patients with juvenile idiopathic arthritis-associated uveitis by conducting a multicenter, randomized-controlled trial at twenty ophthalmology and rheumatology clinics across the U.S., the United Kingdom, and Australia.Saras Ramanathan, MD, Appointed Editor-in-Chief of Journal of Academic Ophthalmology
Saras Ramanathan, MD, has been appointed as Editor-in-Chief of the Journal of Academic Ophthalmology (JAO)UCSF’s Anbukkarasi Muniyandi Accepted into Prestigious Emerging Vision Scientist Program
UCSF vision researcher Anbukkarasi Muniyandi, PhD, has been selected as an “Emerging Vision Scientist (EVS)” by the National Alliance for Eye and Vision Research (NAEVR)How Neurons Build a 3-D Vascular Structure to Keep the Retina Healthy
Understanding how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for conditions like diabetic retinopathy and stroke.A Shining Light for Cataract Patients
A breakthrough in cataract technology is bringing renewed hope to patients seeking improved vision. UCSF cataract surgeons are now using the innovative Light Adjustable Lens™ (LAL) in a growing number of patients who undergo cataract surgery at UCSF Health.